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Mycobacterium bovis, the causative agent of bovine tuberculosis, a major problem for global agriculture,
spreads via an airborne route and is taken up by alveolar macrophages (AM) in the lung. Here, we
describe the ﬁrst next-generation sequencing (RNA-seq) approach to temporally proﬁle miRNA
expression in primary bovine AMs post-infection with M. bovis. One, six, and forty miRNAs were iden-
tiﬁed as signiﬁcantly differentially expressed at 2, 24 and 48 h post-infection, respectively. The differ-
ential expression of three miRNAs (bta-miR-142-5p, bta-miR-146a, and bta-miR-423-3p) was conﬁrmed
by RT-qPCR. Pathway analysis of the predicted mRNA targets of differentially expressed miRNAs suggests
that these miRNAs preferentially target several pathways that are functionally relevant for mycobacterial
pathogenesis, including endocytosis and lysosome trafﬁcking, IL-1 signalling and the TGF-b pathway.
Over-expression studies using a bovine macrophage cell-line (Bomac) reveal the targeting of two key
genes in the innate immune response to M. bovis, IL-1 receptor-associated kinase 1 (IRAK1) and TGF-b
receptor 2 (TGFBR2), by miR-146. Taken together, our study suggests that miRNAs play a key role in
tuning the complex interplay between M. bovis survival strategies and the host immune response.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Tuberculosis (TB) is a major global health threat to both human
and animal populations, which is caused by members of the
intracellular Mycobacterium genus. Currently, one third of the hu-
man population world-wide is estimated to be infected with
Mycobacterium tuberculosis, causing approximately nine million
new cases and 1.3 million deaths every year [1]. Bovine tubercu-
losis, caused by Mycobacterium bovis, is also a signiﬁcant problemd Medical Research Institute,
881 284 053.
).
iversity, PO Box 11060, Ade-
, University of Connecticut,
Ltd. This is an open access article ufor global agriculture. Both M. tuberculosis and M. bovis are mem-
bers of the M. tuberculosis complex (MTBC), a group of highly
related pathogens that are spread via an airborne route and are
taken up by alveolar macrophages (AM) in their respective hosts. It
is well established that M. tuberculosis and M. bovis can block the
antimicrobial systems of the macrophage allowing them to repli-
cate intracellularly and cause disease [2]. There is increasing evi-
dence for the role of the innate immune response in the outcome of
MTBC pathogens [3]. Macrophages are the ﬁrst cells to encounter
mycobacteria, and microarray [4] and RNA-seq experiments [5]
have shown that mRNA expression is substantially altered in
bovine monocyte-derived macrophages (MDM) upon M. bovis
infection in vitro. Changes in the expression of another type of RNA,
microRNAs, however, are less well understood. MicroRNAs (miR-
NAs) are short non-coding RNAs that post-transcriptionally regu-
late gene expression [6] and are known to have roles in manynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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involved in mycobacterial infection [8]. In mice infected with the
vaccine strain M. bovis BCG, downregulated miR-29 expression in
natural killer cells and T cells enhanced IFN-g production, a cyto-
kine important for immunity against intracellular pathogens [9].
Similarly, in human MDMs infected with Mycobacterium avium,
caspase 3 and 7 are downregulated by miRNAs let-7e and miR-29a,
thus inhibiting apoptosis, a defense mechanism against intracel-
lular bacteria [10].
In this paper, we have built upon our previous work proﬁling
miRNA expression in bovine AM using RNA-seq [11], and investi-
gate which miRNAs are differentially expressed in primary bovine
AM at several time-points post-infection with the genome-
sequenced strain of M. bovis 2122/97 in comparison to paired un-
infected controls.2. Materials and methods
2.1. Animals
Ten unrelated age-matched (7e12 weeks) HolsteineFriesian
male calves were used in the challenge experiment. All animals
weremaintained under uniform housing conditions and nutritional
regimens at the UCD Lyons Research Farm (Newcastle, County
Kildare, Ireland). The animals were selected from a herd without a
recent history of bovine tuberculosis infection.2.2. Alveolar macrophage in vitro infection
AMwere harvested by pulmonary lavage of lungs obtained post-
mortem from ten animals, and collected in cryovials as described
before by Magee et al. (2014). The cryovials, containing 2.5  107
AM cells in 1 mL, were stored at 80 C for a period of 20 h after
which they were removed from the freezing containers and
transferred to 140 C freezer storage conditions until further use
[12].
Alveolar macrophage culture was prepared as described by
Magee et al. (2014). Brieﬂy, cryovials were thawed by placing in a
37 C water bath for 1 min. Once thawed, cells were immediately
transferred into 20 ml 37 C pre-warmed R10þ media (RPMI 1640
medium [Invitrogen, Life Technologies Ltd., Paisley, UK], supple-
mented with 10% fetal bovine serum [FBS; SigmaeAldrich, Dublin,
Ireland], [SigmaeAldrich], 2 mM L-glutamine [SigmaeAldrich],
100 mg/ml ampicillin [SigmaeAldrich] and 25 mg/ml gentamycin
[SigmaeAldrich]) and centrifuged (200  g for 5 min). The cell
pellet was resuspended in 15 ml of R10þ media and placed in a
75 cm2 vented culture ﬂask (CELLSTAR Greiner Bio-One Ltd.,
Stonehouse, UK), and incubated for 24 h at 37 C, 5% CO2. After
incubation, alveolar macrophages were seeded in 24-ﬂat well tis-
sue culture plates (Sarstedt Ltd.) at a density of 5  105 cells/well,
and incubated for a further 24 h at 37 C, 5% CO2. Separate infected
and control wells were maintained for each of the 4 time points
(2 h, 6 h, 24 h, 48 h), in addition to the control (0 h). All in vitro
infections were performed in a CL3 laboratory. For this, the media
from all wells was removed and replaced with 1 ml R10 media
containing M. bovis (5  106 cells/ml). The non-infected control
alveolar macrophage samples received 1 ml R10 media only. After
infection, the tissue culture plates were incubated at 37 C, 5% CO2
for 24 h and 48 h. After 2 h infection, the media from all wells of the
24 h and 48 h infection experiments was replaced with fresh R10
media (1 ml per well) and the plates were re-incubated at 37 C, 5%
CO2 until the cells were harvested [12]. Two samples (48 h infected
and control for animal N1861) were excluded due to low cell
numbers, therefore nine animals were used in the 48 h timepoint.2.3. Small RNA preparation
In total, 88 RNA-seq libraries were prepared for sequencing. The
small and total RNA fractions were prepared from the cells using
the RNeasy Plus Mini kit and RNeasy MinElute Cleanup Kit (Qiagen
Ltd., Manchester, UK), according to Appendix E of the manufac-
turer's protocol. The quality and quantity of the prepared total and
small RNA were assessed using the 6000 Nano and small RNA
LabChip kits (Agilent Technologies Ireland Ltd., Cork, Ireland) with
an Agilent 2100 Bioanalyzer (Agilent Technologies Ireland Ltd.). The
total RNA fractions had RIN values between 8.6 and 9.5. Small RNA
concentrations were between 3400 and 17,200 pg/ml, and miRNA
concentrations were between 140 and 1430 pg/ml (Supplementary
Table 1). The small RNA fractions were used for preparing RNA-seq
libraries and for RT-qPCR.
2.4. RNA-seq library preparation
All 88 RNA-seq libraries were prepared with the Illumina Truseq
Small RNA Sample Preparation Kit (Illumina Inc., Madison, WI,
USA), according to the manufacturer's protocol, using 5 ml of the
prepared small RNA. Libraries were sequenced (50 bp single-end)
on 18 lanes of an Illumina HiSeq 2000 machine (BGI Hong Kong,
China). The RNA-seq fastq ﬁles have been uploaded to the NCBI
Gene Expression Omnibus (GEO) database [13] with experiment
series accession number GSE58883.
2.5. Analysis of RNA-seq data
Sample quality and read numbers were assessed using FASTQC
(v0.10.0, http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/).
Cutadapt (v1.2.1) [14] was used to trim 30 adapter sequences from
reads. Reads that were less than 18 nucleotides (nt) after trimming,
and all untrimmed readswere discarded. The remaining reads were
then further ﬁltered using FASTQ Quality Filter (FASTX Toolkit
v0.0.13.2, http://hannonlab.cshl.edu/fastx_toolkit/). Reads where
more than 30% of the bases had a Phred score <20 were removed.
Finally, reads passing all the above ﬁlters were also trimmed at their
ends using FASTQ Quality Trimmer (FASTX Toolkit v0.0.13.2) to
remove low quality bases (Phred score < 20), and reads less than
18 nt after the trimming were discarded. Reads that passed all
quality control steps were aligned to the bovine genome (UMD3.1
assembly [15]) using Novoalign (Novocraft Technologies, v2.08.03)
in ‘miRNA’ mode, allowing one mismatch. Non-uniquely aligning
reads were discarded. HTSeq-count (part of the HTSeq framework,
v0.5.3p3) in ‘union’ modewas then used to count aligned reads that
overlapped with known miRBase (version 19, http://www.mirbase.
org) [16] miRNA gene annotations. To investigate the proportion of
reads sequenced from non-miRNA genes, HTSeq-count was also
used separately to count reads that overlappedwith all bovine gene
annotations from Ensembl version 69. For a summary of the
number of reads at each step, see Supplementary Table 1.
Potentially novel miRNAs were identiﬁed using miRDeep2
(v2.0.0.5) [17]. The predicted novel miRNAs that were indepen-
dently predicted in at least three samples and fulﬁlled all of the
following criteria were submitted tomiRBase: the mature sequence
was expressed in at least ten samples and was expressed at a
minimum of 100 reads per million (RPM); the predictedmiRNA had
a high (>90%) probability of being a true miRNA according to
miRDeep2; and the hairpin structure had a RandFold P value <0.05.
R (v3.0.1, http://www.r-project.org) was used to create the
boxplots and the scatter plots. EdgeR (v3.2.4) [18] was used to
identify statistically signiﬁcant differentially expressed miRNAs
with a paired test, using a generalized linear model (glm) method,
with upper quartile normalization [19]. Differentially expressed
P. Vegh et al. / Tuberculosis 95 (2015) 60e6762miRNAs were deﬁned as those that had both an FDR 0.05 in the
edgeR analysis and were expressed above a threshold of 100 RPM, a
level at which miRNAs are more likely to be functional [20]. Results
were robust for the normalization method used: all differentially
expressed miRNAs were also detected with the other two
normalization methods; TMM (trimmed mean of M-values) and
RLE (relative log expression).2.6. Co-expression and target analysis of miRNA and mRNA data
To identify mRNAs that were potentially regulated by differen-
tially expressed (DE) miRNAs, Pearson correlations were calculated
between DE miRNA expression and mRNA expression (also assayed
by RNA-seq) from the same samples (Nalpas et al., manuscript
submitted) using the Apache Commons Java Statistics Library
(http://commons.apache.org/proper/commons-math). The result-
ing correlation matrix was then ﬁltered to remove both non-
signiﬁcant correlations (critical value for Pearson's correlation for
this matrix is r¼0.2483) and those inverse correlations that were
not supported by miRanda (v3.3a) predicted miRNA-target pairs.
Two-dimensional cluster analysis and visualization, using R (v3.0.1)
hclust and heatmap.plus packages, was then applied to the ﬁltered
correlation matrix. The miRNA-mRNA interaction network was also
visualized with Cytoscape (v3.0.0) [21].2.7. Pathway analysis of predicted miRNA target genes
The predicted target gene IDs of differentially expressedmiRNAs
were converted using 1:1 orthology annotation to human gene IDs
and submitted to InnateDB [22] for pathway analysis. Genes were
submitted in two groups; those that were targets of upregulated
miRNAs, and those that were targets of downregulated miRNAs.
Signiﬁcant pathways were identiﬁed using the Hypergeometric test
and were deﬁned as having a Benjamini and Hochberg corrected P
value of 0.05 [23].Figure 1. MicroRNA expression in unchallenged bovine alveolar macropha2.8. RT-qPCR validation of differentially expressed miRNA genes
The expression of four miRNAs identiﬁed as differentially
expressed in the RNA-seq data (bta-miR-22, bta-miR-142-5p, bta-
miR-146a, and bta-miR-423-3p) was investigated using reverse
transcription quantitative real time PCR (RT-qPCR). Infected and
control samples were compared for nine biological replicates.
Based on the RNA-seq data, bta-miR-16b and bta-miR-26b were
used as non-differentially expressed internal reference transcripts.
The Taqman MicroRNA Reverse Transcription Kit (Applied Bio-
systems, Life Technologies Ltd., Warrington, UK) was used, ac-
cording to the manufacturer's protocol, and using 5 ml of
10  diluted small RNA fraction, in 15 ml reverse transcription re-
action (30 min 16 C, 30 min 42 C, 5 min at 85 C, and then
maintained at 4 C). Taqman MicroRNA Assays (Applied Bio-
systems) with TaqMan Universal Master Mix II (no UNG) (Applied
Biosystems), were used according to the manufacturer's protocol.
A 7500 Fast Real-Time PCR System (Applied Biosystems, soft-
ware version 2.0.6) was used with MicroAmp Fast optical 96-well
plates and Optical Adhesive Films (Applied Biosystems). Ampliﬁ-
cation was performed using 20 ml/well and the following thermal
cycle: 95 C 10 min, and 40 cycles: 95 C for 15 s, 60 C for 1 min.
Technical replication was performed in triplicate and results were
corrected for ampliﬁcation efﬁciency. No ampliﬁcation was
measured in the no template and the reverse transcription control
wells. The one-tailed paired Student's t-test was performed with R
(v3.0.1) on the normalized and efﬁciency-corrected DCt (quantiﬁ-
cation cycle) values, with a signiﬁcance level of 0.05. Using the
Pfafﬂ method [24], fold changes were calculated from the DDCt
values (FC ¼ 2DDCt), using the negative reciprocal for down-
regulated genes (1/FC).2.9. Transfection of Bomac cells with miRNA mimics
Bomac cells were a gift from Prof. Cliona O'Farrelly (Trinity
College Dublin). Although Bomacs poorly replicate all the functionsges. Only those expressed above a threshold of 1000 RPM are shown.
Table 1
Differentially expressed microRNAs in alveolar macrophages challenged with
M. bovis. The results are sorted by time-point and fold-change.
miRNA FC RPM P value FDR
2 h post infection
bta-miR-326 1.91 217.2 6.54  109 2.09  106
24 h post infection
bta-miR-149-5p 1.81 284.4 2.21  104 1.15  102
bta-miR-27a-5p 1.53 390.5 1.18  103 2.94  102
bta-miR-21-3p 1.52 7735.2 1.09  103 2.94  102
bta-miR-147 1.51 2332.4 8.22  104 2.66  102
bta-miR-146a 1.47 13481.5 1.00  103 2.94  102
bta-miR-296 1.79 132 6.21  105 5.03  103
48 h post infection
bta-miR-146b 2.69 1526.5 3.95  106 7.46  105
bta-miR-146a 2.38 14030 7.36  109 2.73  107
bta-miR-147 2.17 2134.7 1.15  107 3.84  106
bta-miR-29c 2.12 381.3 1.35  106 3.23  105
bta-miR-22-3p/bta-
miR-3600
1.96 152949.7 1.35  106 3.23  105
bta-miR-21-3p 1.79 5205.7 6.11  104 4.30  103
bta-miR-142-5p 1.76 15683.4 2.92  105 4.65  104
bta-miR-210 1.73 1324.4 3.70  104 3.20  103
bta-miR-32 1.69 604.6 1.34  104 1.66  103
bta-miR-125a 1.66 1824.2 8.30  104 5.65  103
bta-miR-155 1.65 3165.9 1.89  104 2.11  103
bta-miR-99b 1.63 1326.8 4.72  104 3.50  103
bta-miR-27a-5p 1.63 358.7 4.51  104 3.43  103
bta-miR-149-5p 1.61 366 3.01  104 2.81  103
bta-miR-28 1.6 1845.6 2.33  104 2.43  103
bta-miR-15a 1.54 1626.3 3.73  104 3.20  103
bta-miR-23a 1.51 5730.4 3.03  104 2.81  103
bta-miR-29a 1.49 1627.1 2.88  103 1.66  102
bta-miR-30b-5p 1.47 1671.1 4.06  103 2.08  102
bta-miR-151-5p 1.37 2640.2 5.83  103 2.86  102
bta-miR-92a 1.36 6255.2 9.62  103 4.07  102
bta-let-7d 1.43 12062.2 8.21  103 3.61  102
bta-miR-34a 1.45 479.8 3.71  103 1.97  102
bta-let-7f 1.46 7929 6.79  103 3.19  102
bta-miR-6529 1.52 4179.4 2.18  103 1.33  102
bta-miR-107 1.52 273.8 9.86  104 6.46  103
bta-miR-744 1.55 330.4 4.21  104 3.43  103
bta-miR-328 1.57 229.7 2.96  103 1.68  102
bta-let-7a 1.58 186.8 1.13  102 4.48  102
bta-let-7e 1.62 2038.4 4.38  103 2.18  102
bta-miR-423-5p 1.64 9504.1 3.95  104 3.30  103
bta-miR-423-3p 1.65 9898.1 4.45  106 7.83  105
bta-let-7a-5p 1.84 120.9 2.74  104 2.69  103
bta-miR-345-3p 1.89 996.2 4.31  104 3.43  103
bta-let-7b/bta-
miR-3596
1.91 239.4 5.51  105 7.16  104
bta-miR-128 1.95 115.8 9.18  107 2.55  105
bta-let-7c 2.25 808 4.02  106 7.46  105
bta-miR-874 2.85 126 1.37  1015 2.29  1013
bta-miR-378b 4.75 138.1 1.51  107 4.60  106
bta-miR-296 4.93 191.8 4.54  1020 1.52  1017
FC: fold change; RPM: read per million; FDR: false discovery rate (corrected P value).
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knowledge, the only bovine macrophage cell-line available to un-
dertake the miRNA mimic transfection studies and these experi-
ments are largely independent of these functions. Cells were
cultured in 150 cm2 ﬂasks (CELLSTAR Greiner Bio-One) using RPMI
1640 medium (SigmaeAldrich), supplemented with 10% FBS (Sig-
maeAldrich), Penicillin (50 unit/ml) and Streptomycin (50 mg/ml)
(Pen Strep, Gibco, Life Technologies). For the transfection, cells were
seeded in 6 well ﬂat bottom cell culture plates (CELLSTAR Greiner
Bio-One). Cells were transfected using Opti-MEM 1 (Gibco, Life
Technologies) and Lipofectamine RNAiMAX (Invitrogen, Life Tech-
nologies), according to the manufacturer's protocol and using
75 pmol mimics (Ambion mirVana miRNA mimics, Life Technolo-
gies) per well. Based on the RNA-seq and RT-qPCR results, miR-146a
and miR-146b were selected for the experiment. Additional wells
were treated with negative (scrambled) control mimic, or the
positive control (miR-1). Each well was treated with one miRNA
only. As per the manufacturer's recommendation, downregulation
of miR-1's known target, PTK-9, was measured to conﬁrm that
transfection was successful. Experiments were performed in trip-
licate. After 24 h, cells were washed with PBS (pH 7.4, Gibco, Life
Technologies) and then cells were lysed with the Ambion mirVana
miRNA Isolation Kit (Life Technologies). Total RNA was quantiﬁed
with a Nanodrop ND-1000 and an Agilent 2100 Bioanalyzer, and all
samples had RIN values above 9, and 28S/18S rRNA ratios between
1.8 and 2.3.
2.10. RT-qPCR analysis of target gene downregulation
The expression of two bovine genes, IL-1 receptor-associated
kinase 1 (IRAK1) and TGF-b receptor 2 (TGFBR2), was measured
with RT-qPCR. Five genes, ACTB, GAPDH, H3F3A, PPIA and RPS9,were
tested to ﬁnd suitable internal reference genes. Three reference
genes (GAPDH, H3F3A, RPS9) were selected with the Genorm al-
gorithm [26], using the ReadqPCR and NormqPCR (version 1.8.0) R
packages [27]. The High-Capacity cDNA Reverse Transcription Kit
(Invitrogen, Life Technologies) was used, with 400 ng RNA in 20 ml
reverse transcription reaction (10min 25 C,120min 37 C, 5min at
85 C, and then maintained at 4 C). The Fast SYBR Green Master
Mix (Applied Biosystems) was used for assaying, using 1 ml of the
cDNA. A 7500 Fast Real-Time PCR System was used as described
above, using the following thermal cycling: 95 C 20 s, and 40 cy-
cles: 95 C for 3 s, 60 C for 30 s. The no-template and reverse
transcription control showed that preparations were free of
contamination. For primer sequences see Supplementary Table 2.
Melt curve analysis conﬁrmed speciﬁcity of primers. Treatments
were compared to the scrambled mimic negative control. The two-
tailed two-sample Student's t-test was performed on the normal-
ized and efﬁciency-corrected DCt values, with a signiﬁcance level of
0.05. For the Ct values processed by NormqPCR, please see
Supplementary Table 3. Fold changes were calculated using the
Pfafﬂ method, as described above.
3. Results
A high-throughput sequencing approach was applied to
monitor miRNA expression changes in bovine AM post-infection
with M. bovis and in matched unchallenged control samples. In
total, 2.5 billion reads were generated by sequencing, and
approximately 2 billion reads remained for analysis after adapter
removal and quality control. 93% of reads uniquely aligning to the
genome aligned to annotated miRNAs in the bovine genome, 3.5%
to small nucleolar RNAs (snoRNAs), and the remainder mapped
mainly to other types of RNAs (mRNAs, tRNAs, rRNAs, mtRNAs etc).
miRNA expressionwas highly correlated across biological replicates(Supplementary Figure 1). The most highly expressed miRNAs in
unchallengedmacrophages were bta-miR-21, bta-miR-22, bta-miR-
27a, bta-let-7i and bta-miR-191 (Figure 1). The level of miRNA
expression, however, varied over a wide range, with almost half of
the reads aligning to bta-miR-21 (z430,000 RPM), and the ma-
jority being more lowly expressed (1000e10,000 RPM). For a full
list of the read counts for all miRNAs at all time-points, see
Supplementary Table 4.
3.1. Multiple differentially expressed miRNAs were detected at 2, 24,
and 48 hpi with M. bovis
The edgeR statistical package was used to determine miRNAs
that were differentially expressed in response to M. bovis infection
at 2, 6, 24, and 48 hpi. Only onemiRNA, bta-miR-326, was identiﬁed
Figure 2. Upregulated (A) and downregulated (B) miRNAs in bovine alveolar macrophages isolated from nine animals at 48 h post-infection with M. bovis.
P. Vegh et al. / Tuberculosis 95 (2015) 60e6764as differentially expressed at 2 hpi (FDR  0.05) (Table 1), while no
differentially expressed miRNAs were identiﬁed at 6 hpi. Six miR-
NAs were differentially expressed 24 hpi; of these, ﬁve (bta-miR-
21-3p, bta-miR-27a-5p, bta-miR-146a, bta-miR-147, and bta-miR-
149-5p) were upregulated and one (bta-miR-296) was down-
regulated (FDR 0.05). Forty differentially expressed miRNAs were
identiﬁed at 48 hpi (Figure 2), of which 36 had a >1.5 fold change
difference in expression. All of the miRNAs that were differentially
expressed at 24 hpi were also differentially expressed at 48 hpi.
Among the upregulated miRNAs at 48 hpi, bta-miR-146b had the
highest fold change (FC¼ 2.7), followed by bta-miR-146a (FC¼ 2.4).
Seven members of the bta-let-7 family were found to be down-
regulated post-infection. Interestingly, two highly expressed miR-
NAs, bta-mir-423-3p, and bta-mir-423-5p, from the opposite arm
of the same pre-miRNA, were both downregulated. The full list of
differentially expressedmiRNAs, their read counts and fold changes
are listed in Table 1.3.2. Validation of three differentially expressed miRNAs using RT-
qPCR
The differential expression of four miRNAs (bta-miR-22, bta-
miR-142-5p, bta-miR-146a, and bta-miR-423-3p), found to be
differentially expressed at 48 hpi using RNA-seq (Supplementary
Figure 2), was investigated using reverse transcription quantita-
tive real time PCR (RT-qPCR) in nine biological replicates. Differ-
ential expressionwas conﬁrmed in three out of the four cases: miR-
142-5p (FC ¼ 1.3), miR-146a (FC ¼ 3.0), and miR-423-3p
(FC ¼ 1.7). The upregulation of miR-22 (FC ¼ 1.1) was not statis-
tically signiﬁcant (Figure 3). For the efﬁciency corrected Ct values
for each sample, see Supplementary Table 5.Figure 3. The differential expression of three (bta-miR-142-5p, bta-miR-146a, and bta-
miR-423-3p) out of four miRNAs for the nine animals at 48 hpi was conﬁrmed with RT-
qPCR (white). RNA-seq fold changes for these miRNAs are also shown (light grey).3.3. Two potentially novel bovine miRNAs are predicted from the
sequencing data
Using miRDeep2, two putatively novel bovine miRNAs were
identiﬁed from the sequencing data: bta-mir-10225a (mature
sequence: ccgagccugacagaucacaca), located on chromosome 26,
was found to be expressed in all animals (in 52 samples in total,
with no preference for timepoint or infection status), with a mean
expression of 1890 RPM. A close homolog (with just one nucleotide
mismatch) was also predicted in an adjacent genomic region (bta-
mir-10225b; mature sequence: ucgagccugacagaucacaca), and was
detected in six animals (13 samples) with a mean expression of 950RPM. There are several near-identical copies of these miRNAs in the
same region.3.4. The predicted targets of upregulated miRNAs are enriched for
roles in endocytosis and lysosome function
To identify the potential mRNA targets of differentially
expressed miRNAs, we identiﬁed those mRNAs with expression
values (from Nalpas et al., manuscript submitted) signiﬁcantly
negatively correlated with miRNA expression. These predictions
were further reﬁned by removing those miRNA-target predicted
relationships that were not supported by a predicted miRNA seed
region match in the 30 UTR of the correlated mRNA (Figure 4A,
Supplementary Table 6). This network of miRNA-mRNA in-
teractions was visualized with Cytoscape (Figure 4B). It is apparent
that miR-22-3p, miR-146a and b, miR-147, andmiR-155 share many
targets, suggesting they have a common role. Among the down-
regulated miRNAs, the let-7 family members, and miR-423-3p and
-5p share most of their targets.
Analysis of the predicted target genes using InnateDB (www.
innatedb.com) [22], revealed that the predicted targets of upregu-
lated miRNAs were highly enriched for roles in the lysosome
P. Vegh et al. / Tuberculosis 95 (2015) 60e67 65(FDR  3.2  106) and in endocytosis (FDR  0.02). Key compo-
nents of innate immunity signalling pathways, including the Toll-
like receptor (TLR) pathway, transforming growth factor beta re-
ceptor (TGFBR) signalling pathway, and the IL-10 anti-inﬂamma-
tory signalling pathway, were also predicted to be preferentially
targeted by upregulated miRNAs (Supplementary Table 7).
In comparison, downregulated miRNAs were predicted to
preferentially target IL-1 (FDR  5.4  106) and MAPK signalling
(FDR ¼ 0.0001) pathways, as well as the tumour necrosis factor
receptor 1 (TNFR1) signalling pathway (FDR  0.03) and genes
involved in bacterial invasion (Supplementary Table 7). Addition-
ally, the Toll-like receptor pathway was also targeted by down-
regulated miRNAs. Of the 22 TLR pathway genes predicted to be
targeted, 11 were predicted to be targeted only by downregulated
miRNAs, and 7 only by upregulated miRNAs.3.5. Overexpression of miR-146 results in the transcriptional
suppression of IRAK1 and TGFBR2
We have utilized a miRNA overexpression strategy to validate
the predicted post-transcriptional regulation of two genes in these
pathways bymiR-146, a microRNA shown by RNA-seq and RT-qPCR
to be upregulated in response to M. bovis infection. Successful
transfection of miRNA mimics into a bovine macrophage cell line
(Bomac) was conﬁrmed by the positive control miR-1, which was
observed to three-fold downregulate its target, PTK9. In contrast,
miR-1 did not alter the expression of IRAK1, and only marginally
(1.2 fold upregulation) altered TGFBR2 mRNA levels
(Supplementary Table 3). miR-146a or miR-146b was predicted
from our computational analyses to downregulate IRAK1, and
indeed, transfection (i.e. overexpression) of miRNA mimics for
these miRNAs into Bomacs led to a more than three-fold suppres-
sion of IRAK1 transcription (Figure 5), a central kinase in the TLR
and IL-1 pathways [28]. Another predicted target of bta-miR-146a
and bta-miR-146b, TGFBR2, which is part of the TGF-b receptorFigure 4. A) Two-dimensional cluster analysis and heatmap visualization of signiﬁcant corre
signiﬁcant correlations and those not supported by a 30 UTR miRNA seed match are shown in
dendrogram largely aligns with the upregulated (red) and downregulated miRNAs (green). B
with M. bovis. Targets are predicted based on a signiﬁcant negative correlation between miR
mRNA. Squares ¼ miRNAs; Circles ¼ mRNAs. Red ¼ upregulated; Green ¼ downregulate
Supplementary Table 6 for details of targeted mRNAs.pathway, was also downregulated 1.5 fold upon transfection with
mimics (Figure 5).4. Discussion
In this study, we have used high-throughput sequencing to
proﬁle miRNA expression at multiple time-points, in primary
bovine alveolar macrophages infected with M. bovis, the causative
agent of bovine TB. Over the time-course, 41 miRNAs were identi-
ﬁed as being signiﬁcantly differentially expressed in response to
M. bovis infection. The majority of miRNAs were differentially
expressed only after 48 hpi. Several of the differentially expressed
miRNAs have been shown to have regulatory roles in monocytes
and macrophages and during infection. For example, miR-149-5p,
which was upregulated in our study at 24 and 48 hpi, has also
been shown to be upregulated in murine bone-marrow derived
macrophages infected with Listeria monocytogenes [29]. Another
highly expressed miRNA detected in our study, miR-27, has previ-
ously been shown to have a role in the activation of human mac-
rophages [30,31].
Many of the differentially expressed miRNAs have also been
shown to have a role in other mycobacterial infections. The most
highly expressed miRNA at 24 hpi, bta-miR-146a, was upregulated
more than two-fold, and has also been found to be upregulated in
human MDMs after M. avium infection [10]. Another example at
24 hpi is bta-miR-21-3p. MiR-21 has a well-established role in
immunity and has been shown to target the vitamin D-dependent
antimicrobial pathway inMycobacterium leprae infectedmonocytes
[32,33]. MicroRNAs bta-mir-423-3p, and bta-mir-423-5p, which
were downregulated in response toM. bovis infection in our study,
have also been found to be downregulated in humanMDM infected
with M. avium [10], and are involved in regulating chemokine
expression and apoptosis related pathways. Although these ﬁnd-
ings show that not all observed changes are M. bovis-speciﬁc, the
differentially expressed miRNAs may serve as potential biomarkerlations (shown as coloured lines) between miRNA and mRNA expression at 48 hpi. Non-
grey. Please see the colour key in the ﬁgure. The primary split in the upper hierarchical
) A network of the predicted mRNA targets of differentially expressed miRNAs at 48 hpi
NA and mRNA expression and the presence of a miR and a seed match in the correlated
d. Lysosome and endocytosis pathway genes are shown as black circles. Please see
Figure 5. Transfection of miRNA mimics for miR-146a or miR-146b into a bovine
macrophage cell line (Bomac) led to a 3 fold suppression of IRAK1 transcription, and a
1.5 fold downregulation of TGFBR2 in comparison to a scrambled control miRNA, as
measured by RT-qPCR. Successful transfection was conﬁrmed by the positive control
miR-1, which was observed to downregulate its target, PTK9, by 3 fold.
P. Vegh et al. / Tuberculosis 95 (2015) 60e6766candidates for M. bovis infection in cattle, for example, as was
suggested for miR-155 [34].
Pathway analysis of the predicted mRNA targets of DE miRNAs
suggests that these miRNAs preferentially target several pathways
that are functionally relevant for mycobacterial pathogenesis. The
predicted targets of upregulated miRNAs at 48 hpi, for example,
were statistically enriched for functions in the lysosome and in the
endocytosis pathway. These pathways were predicted to be tar-
geted by multiple miRNAs including bta-miR-15a, bta-miR-21-3p,
bta-miR-22-3p, bta-miR-23a, bta-miR-30b-5p and bta-miR-142-5p.
A key feature of mycobacteria is their ability to survive and
reproduce in the phagosome by retarding maturation of the
phagosome along the endosomal-lysosomal pathway and blocking
fusion with the lysosome [35]. Mycobacteria also enhance phag-
osome fusion with early endosomes, possibly providing access to
host nutrients and secreted glycoproteins [36]. In our analysis, the
endocytosis pathway was predicted to be targeted mainly through
several members of the membrane trafﬁcking regulator Rab family,
namely, RAB22A, RAB4A, RAB5B, RAB5C, and RAB7A, in addition to
rabaptin (RABEP1) and the RAB11 family interacting protein 5
(RAB11FIP5). Autophagy is an effective innate defence mechanism
for eliminating mycobacteria [37,38]. Recently, the Rab protein
family was found to be necessary for autophagic clearance of
mycobacteria and the knockdown of Rab proteins resulted in
increased M. bovis-BCG survival [39]. Our results therefore suggest
that M. bovis utilizes host miRNAs as part of its strategy to
manipulate these processes for its own beneﬁt and survival.
We have also shown, that overexpression of miR-146a and miR-
146b, which are upregulated during M. bovis infection, leads to a
downregulation of IRAK1, a central kinase in IL-1 signal trans-
duction [40], TLR signalling and in the Type I Interferon Pathway
[41]. The targeting of IRAK1 by miR-146a/b has also been demon-
strated in human [42] and mouse [43]. IL-1 receptor signalling is
required for the innate response to M. tuberculosis and IL1R1-
deﬁcient mice display a dramatic defect of early control of MTB
infection [44]. Thus, this may be another example of M. bovis
exploiting host miRNAs for its own beneﬁt. Pathway analysis,
however, has also revealed that despite the targeting of IRAK1 by
upregulated miR-146a/b, many other members of this pathway
were statistically enriched as targets of downregulated miRNAs,
which would be predicted to transcriptionally upregulate thesegenes in the IL-1 pathway. This suggests that both the pathogen and
the host are battling for the control of this central pro-
inﬂammatory pathway at the post-transcriptional level.
The transforming growth factor beta (TGF-b) pathway was also
predicted to be signiﬁcantly targeted by upregulated miRNAs and
we have shown that the overexpression of miR-146a or miR-146be
two of the upregulated miRNAs e results in the downregulation of
TGFBR2, one the receptors for the TGF-b pathway. TGF-b signalling
has a well-established role in tuberculosis pathogenesis [45]. Thus,
the post-transcriptional targeting of this pathway by upregulated
miRNAs may be an example of the host immune response utilizing
miRNAs for the beneﬁt of the host.
In conclusion, our work, which investigates the post-
transcriptional regulation of the innate immune response by miR-
NAs in alveolar macrophages, the natural host cell-type forM. bovis,
suggests that miRNAs play a key role in ﬁnely tuning the complex
interplay and tightly controlled balance between pathogen survival
strategies and the host immune response.
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